462 related articles for article (PubMed ID: 28794294)
21. Renal dysfunction and intragraft proMMP9 activity in renal transplant recipients with interstitial fibrosis and tubular atrophy.
Racca MA; Novoa PA; Rodríguez I; Della Vedova AB; Pellizas CG; Demarchi M; Donadio AC
Transpl Int; 2015 Jan; 28(1):71-8. PubMed ID: 25179305
[TBL] [Abstract][Full Text] [Related]
22. Distinctive expression signatures of serum microRNAs in ischaemic stroke and transient ischaemic attack patients.
Wu J; Fan CL; Ma LJ; Liu T; Wang C; Song JX; Lv QS; Pan H; Zhang CN; Wang JJ
Thromb Haemost; 2017 May; 117(5):992-1001. PubMed ID: 28251236
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA 628-5p as a Novel Biomarker for Cardiac Allograft Vasculopathy.
Neumann A; Napp LC; Kleeberger JA; Benecke N; Pfanne A; Haverich A; Thum T; Bara C
Transplantation; 2017 Jan; 101(1):e26-e33. PubMed ID: 27653298
[TBL] [Abstract][Full Text] [Related]
24. Increased urinary cystatin C level is associated with interstitial fibrosis and tubular atrophy in kidney allograft recipients.
Mendes Mde F; Salgado JV; de Ribamar Lima J; Ferreira TC; Silva GE; Filho NS
Clin Biochem; 2015 May; 48(7-8):546-9. PubMed ID: 25746149
[TBL] [Abstract][Full Text] [Related]
25. Kidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy.
Nogare AL; Veronese FV; Carpio VN; Montenegro RM; Pedroso JA; Pegas KL; Gonçalves LF; Manfro RC
BMC Nephrol; 2015 Feb; 16():19. PubMed ID: 25884518
[TBL] [Abstract][Full Text] [Related]
26. Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease.
Yao Q; Wang X; He W; Song Z; Wang B; Zhang J; Qin Q
Endocrine; 2019 Jul; 65(1):102-109. PubMed ID: 30949910
[TBL] [Abstract][Full Text] [Related]
27. Expression levels of atherosclerosis-associated miR-143 and miR-145 in the plasma of patients with hyperhomocysteinaemia.
Liu K; Xuekelati S; Zhang Y; Yin Y; Li Y; Chai R; Li X; Peng Y; Wu J; Guo X
BMC Cardiovasc Disord; 2017 Jun; 17(1):163. PubMed ID: 28633641
[TBL] [Abstract][Full Text] [Related]
28. Screening and identification of four serum miRNAs as novel potential biomarkers for cured pulmonary tuberculosis.
Wang C; Yang S; Liu CM; Jiang TT; Chen ZL; Tu HH; Mao LG; Li ZJ; Li JC
Tuberculosis (Edinb); 2018 Jan; 108():26-34. PubMed ID: 29523324
[TBL] [Abstract][Full Text] [Related]
29. Circulating microRNAs as potential biomarkers for the identification of vascular dementia due to cerebral small vessel disease.
Prabhakar P; Chandra SR; Christopher R
Age Ageing; 2017 Sep; 46(5):861-864. PubMed ID: 28633305
[TBL] [Abstract][Full Text] [Related]
30. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
[TBL] [Abstract][Full Text] [Related]
31. Antagonism of profibrotic microRNA-21 improves outcome of murine chronic renal allograft dysfunction.
Schauerte C; Hübner A; Rong S; Wang S; Shushakova N; Mengel M; Dettling A; Bang C; Scherf K; Koelling M; Melk A; Haller H; Thum T; Lorenzen JM
Kidney Int; 2017 Sep; 92(3):646-656. PubMed ID: 28396121
[TBL] [Abstract][Full Text] [Related]
32. Association between Circulating MicroRNAs (miR-21-5p, miR-20a-5p, miR-29b-3p, miR-126-3p and miR-101-3p) and Chronic Allograft Dysfunction in Renal Transplant Recipients.
Chen YJ; Hsu CT; Tsai SF; Chen CH
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293110
[TBL] [Abstract][Full Text] [Related]
33. Endothelium-enriched microRNAs as diagnostic biomarkers for cardiac allograft vasculopathy.
Singh N; Heggermont W; Fieuws S; Vanhaecke J; Van Cleemput J; De Geest B
J Heart Lung Transplant; 2015 Nov; 34(11):1376-84. PubMed ID: 26198441
[TBL] [Abstract][Full Text] [Related]
34. A circulating exosomal microRNA panel as a novel biomarker for monitoring post-transplant renal graft function.
Chen Y; Han X; Sun Y; He X; Xue D
J Cell Mol Med; 2020 Oct; 24(20):12154-12163. PubMed ID: 32918330
[TBL] [Abstract][Full Text] [Related]
35. Expression of microRNA-129-2-3p and microRNA-935 in plasma and brain tissue of human refractory epilepsy.
Sun Y; Wang X; Wang Z; Zhang Y; Che N; Luo X; Tan Z; Sun X; Li X; Yang K; Wang G; Luan L; Liu Y; Zheng X; Wei M; Cheng H; Yin J
Epilepsy Res; 2016 Nov; 127():276-283. PubMed ID: 27689807
[TBL] [Abstract][Full Text] [Related]
36. Lower Circulating Cytotoxic T-Cell Frequency and Higher Intragraft Granzyme-B Expression Are Associated with Inflammatory Interstitial Fibrosis and Tubular Atrophy in Renal Allograft Recipients.
Yadav B; Prasad N; Agrawal V; Agarwal V; Jain M
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374379
[No Abstract] [Full Text] [Related]
37. Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?
Haas M
Curr Opin Nephrol Hypertens; 2014 May; 23(3):245-50. PubMed ID: 24626060
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis.
Ben-Dov IZ; Muthukumar T; Morozov P; Mueller FB; Tuschl T; Suthanthiran M
Transplantation; 2012 Dec; 94(11):1086-94. PubMed ID: 23131772
[TBL] [Abstract][Full Text] [Related]
39. Differential MicroRNA Expressions in Human Peripheral Blood Mononuclear Cells Are Predictive of Renal Allograft Function.
Li F; Qian W; Quan X; Yang H; Zhao G; Wei L
Transplant Proc; 2019 Apr; 51(3):715-721. PubMed ID: 30979455
[TBL] [Abstract][Full Text] [Related]
40. Free microRNA levels in plasma distinguish T-cell mediated rejection from stable graft function after kidney transplantation.
Matz M; Lorkowski C; Fabritius K; Durek P; Wu K; Rudolph B; Neumayer HH; Mashreghi MF; Budde K
Transpl Immunol; 2016 Nov; 39():52-59. PubMed ID: 27663089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
